Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating azacitidine in combination with entinostat in advanced breast cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer
• Stage Iiic Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Entinostat (entinostat)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Carcinoma, Recurrent Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-03-17